Pharmacokinetics of Praziquantel in Schistosoma Mansoni- and Schistosoma Haematobium-infected School- and Preschool-aged Children Publication Pharmacokinetics of Praziquantel in Schistosoma Mansoni- and Schistosoma Haematobium-infected School- and Preschool-aged Children Certara2018 年 6 月 4 日
Population Pharmacokinetics of Vancomycin in Patients Undergoing Allogeneic Hematopoietic Stem-cell Transplantation Publication Population Pharmacokinetics of Vancomycin in Patients Undergoing Allogeneic Hematopoietic Stem-cell Transplantation Certara2018 年 5 月 15 日
A Randomized, First-in-human, Healthy Volunteer Trial of Sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway Publication 特异性抑制经典补体途径的人源化抗体 Sutimlimab 的首次人体健康志愿者随机试验 Certara2018 年 5 月 8 日
Pharmacokinetic Properties of a Sufentanil Sublingual Tablet Intended to Treat Acute Pain Publication Pharmacokinetic Properties of a Sufentanil Sublingual Tablet Intended to Treat Acute Pain Certara2018 年 5 月 1 日
Metformin Treatment of Type 2 Diabetes Mellitus in Pregnancy: Update on Safety and Efficacy Publication Metformin Treatment of Type 2 Diabetes Mellitus in Pregnancy: Update on Safety and Efficacy Certara2018 年 4 月 25 日
Using M&S to Evaluate Oncology Drug Dosing Blog Using M&S to Evaluate Oncology Drug Dosing There are numerous challenges in developing oncology drugs: (1) they are often very toxic which…Certara2018 年 4 月 13 日
Population Pharmacokinetics of Intravenous Linezolid in Premature Infants Publication Population Pharmacokinetics of Intravenous Linezolid in Premature Infants Certara2018 年 4 月 9 日
Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations Publication Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations Certara2018 年 4 月 1 日
An Analysis on Distribution and Inter-relationships of Biomarkers Under Rivaroxaban in Japanese Patients with Non-valvular Atrial Fibrillation (CVI ARO 1) Publication An Analysis on Distribution and Inter-relationships of Biomarkers Under Rivaroxaban in Japanese Patients with Non-valvular Atrial Fibrillation (CVI ARO 1) Certara2018 年 3 月 15 日
Using Virtual Twin® Technology to Predict Drug Exposure in Individual Patients On-Demand Webinar Using Virtual Twin® Technology to Predict Drug Exposure in Individual Patients In this webinar, Dr. Tom Polasek, a clinical pharmacologist at Certara Strategic Consulting, explained how…Certara2018 年 3 月 8 日